Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Hers vs Pallas Health

By GLP-1 ScorecardUpdated

Hers
Site position #344

Lower score

Pallas HealthFactor scores not reassessed.
Site position #142

Higher score

Score comparison

Pallas Health has the higher recorded score — 69.3/100 to 60.7/100.

Pallas Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Pallas advertises four-week renewal or an annual option for compounded injections. Ask for the full amount due and confirm when a prescribed order becomes final.

Before you choose

Before comparing the headline prices, the Hers review and the Pallas Health review set out what each semaglutide figure in the table below covers, including whether the medication is a brand-name product billed by a pharmacy. Brand-name and compounded prices are different products, so set like against like before treating either one as cheaper.

If neither one fits, Hers vs Ro and Liberty vs Pallas Health compare each of them with another graded program, and the list of alternatives to Hers ranks the programs closest to Hers on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.

Of the sellers that pay us a commission, the WellMedr review covers one graded close to these two, at 63.2/100. That relationship never changes a grade, and the review lists what we could not verify.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valuePallas Health +1
54
55
Dose & formulationHers +1
77
76
Clinical oversightPallas Health +29
55
84
Labs & monitoringEven
52
52
FulfillmentPallas Health +5
81
86
Contract termsPallas Health +27
41
68
Hers · top barPallas Health · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricHersPallas Health
WeighScore60.7/10069.3/100
GradeCC
Site position#344#142
SemaglutideFrom $149/mo (Wegovy pill; plus required care: $39 first month, then $149/mo)$139 first period, then $199 every four weeks (compounded; confirm selected quote)
TirzepatideFrom $299/mo (Zepbound vial or KwikPen; plus required care: $39 first month, then $149/mo)$179 first period, then $299 every four weeks (compounded; confirm selected quote)
CoverageNot available in every state; confirm eligibilityConfirm treatment and visit requirements for your state
Brand-name accessYesYes
Oral / sublingualYesNot confirmed
Hers

Site position #344 · C

FDAWarning letter issued to Hims & Hers Health, Inc. dba Hers in September 2025. See the FDA warning-letter database.

Strengths

  • Branded Wegovy pill and pen, plus Zepbound vial or KwikPen options listed
  • Ongoing provider messaging and monthly care-team follow-ups described
  • Published membership and medication charges can be compared separately

What to consider

  • Required care membership is $39 first month, then $149 monthly, extra to medication
  • Membership and medication cancellation are separate; shipped prepaid supply may keep membership charges payable
  • Availability and medication prices depend on state, product, dose and plan
  • FDA issued Hims & Hers Health, Inc. dba Hers a warning letter in September 2025 concerning compounded-semaglutide promotion; this is distinct from current branded-product approval
Pallas Health

Site position #142 · C

Factor scores not reassessed.

Strengths

  • Publishes first-period and four-week renewal amounts
  • Explains when the charge is triggered and how to cancel future renewal
  • Terms link to a pharmacy partner directory

What to consider

  • Annual monthly equivalents do not establish the selected debit
  • Once prescribed, the current cycle ordinarily is not prorated or refunded
  • The six-month promise has separate eligibility and timing requirements

Featured provider

CoreAge Rx

CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.

Commercial relationships affect this placement. The score comparison above is separate.

Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.

← Back to the scorecard